Despite the negative prognostic influence of TP53 mutations in patients with DLBCL which was described by different groups, the prognosis of the patients in our cohort was favourable and five out of six patients in our cohort with this alteration were still alive with no signs of lymphoma recurrence at the last point of follow-up [16,17]. Here, TP53 is linked to diffuse large B-cell lymphoma.